Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Recruiting · NCT02021604 · Registry updated 2024-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma | Adenoma, Islet Cell, Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Infant, Newborn, Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenoma, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hyperinsulinism, hypoglycemia, malignant endocrine neoplasm, metabolic disease, neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm | Recruiting | Phase 1 | 2024-07-16 | NCT02021604 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cook Children's Health Care System | 10 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cook Children's Medical Center | Fort Worth | United States | 111 |